| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3584903efe1babebbd056e855a2cc2b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed3a7f7ae65317aed41e3e018c547c81 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-202 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9711 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-9711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 |
| filingDate |
2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47c6c2c86e9e424321425a65705a701c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da1cdd72b0de4a28633accf2c30a002e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2590ada447b9eddffa5ea8bfebd3c198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53ad940e3bc7f52f5f302d99e7386cd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c91d123b902681516a5ed84ba8813ba8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53757555764891dadf2db925c697f168 |
| publicationDate |
2019-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101935471-B1 |
| titleOfInvention |
Composition for Anti-inflammation Using an Enzyme Digest of Sargassum horneri |
| abstract |
The present invention inhibits the production of NO, PGE 2 , inflammatory cytokines (TNF-a and IL-6) in a concentration-dependent manner in a mouse macrophage cell line (RAW 264.7 cells) stimulated by lipopolysaccharide (LPS) (P38 MAPK) and ERK1 / 2 (extracellular signal-regulated kinases 1/2), which inhibit NF-κB translocation to the nucleus and induce activation of NF-κB Discloses a composition for antiinflammation using a hydrogel-treated cellulase or a polysaccharide isolated therefrom. |
| priorityDate |
2017-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |